Latest raise
$87M
Date raised
November 18, 2026
Round
Series C
InvestorsF-Prime Capital, New Enterprise Associates, RA Capital Management, Sanofi Ventures
Websitevitrivaxbio.com
About Romulo Colindres
a vaccine development and formulation technology company
- Who is Romulo Colindres?
- Romulo Colindres is listed as President/CEO at VitriVax, a biotechnology company.
- How much did VitriVax raise?
- VitriVax raised $87M in a Series C round on November 18, 2026 (4 days ago). Backed by F-Prime Capital, New Enterprise Associates, RA Capital Management, Sanofi Ventures.
Get newly funded founders every week
A free weekly list of startups that just raised.